deltatrials
Completed PHASE1 INTERVENTIONAL 4-arm NCT01586455

Human Placental-Derived Stem Cell Transplantation (HPDSC)

A Single-Arm Study to Assess the Safety of Transplantation With Human Placental-Derived Stem-Cells Combined With Unrelated and Related Cord Blood in Subjects With Certain Malignant Hematologic Diseases and Non-Malignant Disorders

Sponsor: New York Medical College

Conditions Acute Lymphocytic Leukemia Acute Myelogenous Leukemia Adrenoleukodystrophy Amegakaryocytic Thrombocytopenia Batten Disease Diamond-Blackfan Anemia Fucosidosis Gaucher's Disease Krabbe's Disease Metachromatic Leukodystrophy Mucopolysaccharidosis I Mucopolysaccharidosis VI Myelodysplastic Syndrome Niemann-Pick Disease Severe Aplastic Anemia Wolman Disease
Interventions Human Placental Derived Stem Cell
Updated 11 times since 2017 Last updated: Oct 24, 2022 Started: Apr 30, 2013 Primary completion: Jun 30, 2020 Completion: Sep 30, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Acute Lymphocytic Leukemia and Acute Myelogenous Leukemia, this trial is completed. The trial is conducted by New York Medical College and has accumulated 11 data snapshots since 2013. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotRecruiting~Feb 2017 – ~Jan 2018 · 11 months · monthly snapshotRecruiting~Jan 2018 – ~Jun 2018 · 5 months · monthly snapshotActive Not Recruiting~Jun 2018 – ~Jan 2020 · 19 months · monthly snapshotActive Not Recruiting~Jan 2020 – ~Mar 2020 · 2 months · monthly snapshotUnknown Status~Mar 2020 – ~Jan 2021 · 10 months · monthly snapshotActive Not Recruiting~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshotActive Not Recruiting~Dec 2021 – ~Nov 2022 · 11 months · monthly snapshotActive Not Recruiting~Nov 2022 – ~Jul 2024 · 20 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

11 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  3. Nov 2022 — Jul 2024 [monthly]

    Completed PHASE1

    Status: Active Not Recruiting → Completed

  4. Dec 2021 — Nov 2022 [monthly]

    Active Not Recruiting PHASE1

  5. Jan 2021 — Dec 2021 [monthly]

    Active Not Recruiting PHASE1

▶ Show 6 earlier versions

  1. Mar 2020 — Jan 2021 [monthly]

    Active Not Recruiting PHASE1

    Status: Unknown Status → Active Not Recruiting

  2. Jan 2020 — Mar 2020 [monthly]

    Unknown Status PHASE1

    Status: Active Not Recruiting → Unknown Status

  3. Jun 2018 — Jan 2020 [monthly]

    Active Not Recruiting PHASE1

  4. Jan 2018 — Jun 2018 [monthly]

    Active Not Recruiting PHASE1

    Status: Recruiting → Active Not Recruiting

  5. Feb 2017 — Jan 2018 [monthly]

    Recruiting PHASE1

  6. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE1

    First recorded

Apr 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • New York Medical College
Data source: New York Medical College

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations